Dyne Therapeutics Inc (DYN)

14.33 -0.04  -0.28% NASDAQ Oct 22, 16:00 14.26 -0.07  -0.49% After-Hours: 20:00 USD

Dyne Therapeutics Free Cash Flow (Quarterly):

-46.89M for June 30, 2021
View 4,000+ financial data types
View Full Chart

Free Cash Flow (Quarterly) Chart

Export Data
Save Image
Print Image

Historical Free Cash Flow (Quarterly) Data

View and export this data going back to 2020. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
June 30, 2021 -46.89M
March 31, 2021 -18.40M
Dec. 31, 2020 -20.76M
Sept. 30, 2020 -12.04M
June 30, 2020 -7.369M
March 31, 2020 -7.499M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.


Free Cash Flow Definition

Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.

Read full definition.

Free Cash Flow (Quarterly) Benchmarks

Veracyte Inc 0.36M
Moderna Inc 4.033B
BridgeBio Pharma Inc -94.00M

Free Cash Flow (Quarterly) Range, Past 5 Years

Minimum -46.89M Jun 2021
Maximum -7.369M Jun 2020
Average -18.83M


Dyne Therapeutics EPS beats by $0.10
SA Breaking News 05/06 08:10 ET



Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.